|Bid||4.2900 x 1400|
|Ask||0.0000 x 800|
|Day's Range||4.1800 - 4.5000|
|52 Week Range||3.6400 - 5.0100|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 10, 2020 - Feb 14, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.25|
Repro Med Systems, Inc. dba KORU Medical Systems today announced that management is scheduled to present at the following investor conferences in November:
Repro Med Systems, Inc. dba KORU Medical Systems today announced that it will release its financial results for the third quarter and nine months ended September 30, 2019 after the close of the financial markets on Tuesday, November 5, 2019.
Repro Med Systems, Inc. dba KORU Medical Systems today announced a poster presentation at the IgNS 2019 National Conference in Las Vegas that evaluates the performance of the Company’s HIgH-Flo Super26™ Subcutaneous Safety Needle Set against that of the Company’s standard HIgH-Flo™ 26G Needle Set in areas including patient infusion time, tolerability, comfort, and overall satisfaction.